DOI QR코드

DOI QR Code

A Case of Radiation Bronchitis Induced Massive Hemoptysis after High-Dose-Rate Endobronchial Brachytherapy

  • Lee, Seok Jeong (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Lee, Jong-Young (Department of Radiation Oncology, Yonsei University Wonju College of Medicine) ;
  • Jung, Soon Hee (Department of Pathology, Yonsei University Wonju College of Medicine) ;
  • Lee, Shun Nyung (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Lee, Ji-Ho (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Kim, Chong Whan (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Jung, Saehyun (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Jung, Ye-Ryung (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Lee, Won-Yeon (Department of Internal Medicine, Yonsei University Wonju College of Medicine)
  • Received : 2012.04.22
  • Accepted : 2012.07.03
  • Published : 2012.12.30

Abstract

High-dose-rate endobronchial brachytherapy (HDREB) have been used as the treatment of early endobronchial cancer, as well as for palliation of advanced cancer. However, fatal hemoptysis can occur after HDREB at the rate of 7~32%. We report a case of massive hemoptysis due to radiation bronchitis developed after HDREB. A 67-year-old man was treated with HDREB for early endobronchial cancer on the left upper lobe bronchus. He complained of persistent cough from 4 weeks after completion of HDREB. Radiation bronchitis was observed on the bronchoscopy at 34 weeks, and it was progressed from mucosal swelling and exudate formation to necrosis and ulceration without local relapse. In addition, he died of massive hemoptysis after 15 months. The patient had no sign or radiologic evidences to predict the hemoptysis. This case implies that HDREB directly contributes to an occurrence of a fatal hemoptysis, and follow-up bronchoscopy is important to predict a progression of radiation bronchitis and fatal hemoptysis.

Keywords

References

  1. Bedwinek J, Petty A, Bruton C, Sofield J, Lee L. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1992;22:23-30.
  2. Ozkok S, Karakoyun-Celik O, Goksel T, Mogulkoc N, Yalman D, Gok G, et al. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Lung Cancer 2008;62:326-33.
  3. Marsiglia H, Baldeyrou P, Lartigau E, Briot E, Haie- Meder C, Le Chevalier T, et al. High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 2000;47:665-72.
  4. Hennequin C, Bleichner O, Trédaniel J, Quero L, Sergent G, Zalcman G, et al. Long-term results of endobronchial brachytherapy: a curative treatment? Int J Radiat Oncol Biol Phys 2007;67:425-30.
  5. Aumont-le Guilcher M, Prevost B, Sunyach MP, Peiffert D, Maingon P, Thomas L, et al. High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients. Int J Radiat Oncol Biol Phys 2011;79:1112-6.
  6. Hara R, Itami J, Aruga T, Kozuka T, Nakajima K, Yamashita H, et al. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies. Cancer 2001;92:2623-7.
  7. Hennequin C, Tredaniel J, Chevret S, Durdux C, Dray M, Manoux D, et al. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis. Int J Radiat Oncol Biol Phys 1998;42:21-7.
  8. Gollins SW, Ryder WD, Burt PA, Barber PV, Stout R. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 1996;39:105-16.
  9. Chung MP, Kwon OJ, Choi DR, Huh SJ, Lim DH, Kim MK, et al. Short-term results of endobronchial brachytherapy for malignant airway obstructions. J Korean Soc Ther Radiol 1996;14:299-306.
  10. Park YJ, Kim CY, Kim KT, Yang DS, Lee S. The palliative effect of endobronchial brachytherapy for previously irradiated patients with lung cancer. J Korean Soc Ther Radiol Oncol 2007;25:177-84.
  11. Speiser BL, Spratling L. Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. Int J Radiat Oncol Biol Phys 1993;25:589-97.
  12. Taulelle M, Chauvet B, Vincent P, Félix-Faure C, Buciarelli B, Garcia R, et al. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 1998;11:162-8.
  13. Edell ES, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc 1987;62:8-14.
  14. Maiwand MO, Asimakopoulos G. Cryosurgery for lung cancer: clinical results and technical aspects. Technol Cancer Res Treat 2004;3:143-50.
  15. Matsumoto I, Oda M, Imagawa T, Yachi T, Fujimori H, Watanabe G. Management of tracheobronchial ulceration induced by high-dose brachytherapy. Ann Thorac Surg 2009;87:1301-3.

Cited by

  1. Endobronchial brachytherapy combined with surgical procedure for synchronous multiple primary lung cancer: A case report vol.12, pp.8, 2012, https://doi.org/10.1111/1759-7714.13911